Total Clarity Wealth Management, Inc. Clovis Oncology, Inc. Transaction History

Total Clarity Wealth Management, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 03, 2022	SELL	$2.7 - $4.76 $1,620 - $2,856	-600 Closed	0 $0
Q3 2021 Oct 21, 2021	BUY	$4.06 - $5.8 $2,435 - $3,480	600 New	600 $3,000
Q2 2021 Jul 26, 2021	SELL	$5.02 - $7.05 $3,011 - $4,230	-600 Closed	0 $0
Q1 2021 May 05, 2021	BUY	$4.81 - $10.34 $2,885 - $6,204	600 New	600 $4,000
Q1 2020 Apr 24, 2020	SELL	$3.77 - $11.0 $2,262 - $6,600	-600 Closed	0 $0
Q4 2019 Feb 27, 2020	BUY	$3.0 - $16.43 $1,800 - $9,858	600 New	600 $6,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Total Clarity Wealth Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Total Clarity Wealth Management, Inc. with notifications on news.